Cargando…
Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India
BACKGROUND: Over the years, there has been introduction of newer drugs, like bendamustine and ibrutinib, for the management of chronic lymphocytic leukaemia (CLL). Though these drugs lead to better survival, they are also associated with higher cost. The existing evidence on cost effectiveness of th...
Autores principales: | Nehra, Prerika, Chauhan, Akashdeep Singh, Malhotra, Pankaj, Kumar, Lalit, Singh, Ashish, Gupta, Nidhi, Mehra, Nikita, Mathew, Anisha, Kataki, Amal Chandra, Gupta, Sudeep, Prinja, Shankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305972/ https://www.ncbi.nlm.nih.gov/pubmed/37383548 http://dx.doi.org/10.1016/j.lansea.2023.100201 |
Ejemplares similares
-
Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India—A Model-Based Economic Analysis
por: Gupta, Nidhi, et al.
Publicado: (2022) -
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India
por: Gupta, Dharna, et al.
Publicado: (2023) -
Financial toxicity of cancer treatment in India: towards closing the cancer care gap
por: Prinja, Shankar, et al.
Publicado: (2023) -
Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol
por: Prinja, Shankar, et al.
Publicado: (2021) -
Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India
por: Gupta, Nidhi, et al.
Publicado: (2021)